Adams Diversified Equity Fund, Inc. Chemo Centryx, Inc. Transaction History

Adams Diversified Equity Fund, Inc.

$2.69 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Oct 28, 2019	SELL	$6.47 - $8.96 $47,878 - $66,304	-7,400 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$8.31 - $14.85 $68,973 - $123,255	-8,300 Reduced 52.87%	7,400 $69,000
Q1 2019 Apr 26, 2019	SELL	$10.01 - $13.89 $229,229 - $318,081	-22,900 Reduced 59.33%	15,700 $218,000
Q4 2018 Feb 14, 2019	SELL	$9.15 - $12.26 $14,640 - $19,616	-1,600 Reduced 3.98%	38,600 $421,000
Q3 2018 Oct 29, 2018	SELL	$10.49 - $13.72 $29,372 - $38,416	-2,800 Reduced 6.51%	40,200 $508,000
Q2 2018 Jul 26, 2018	BUY	$10.62 - $13.98 $456,659 - $601,140	43,000 New	43,000 $566,000
Q4 2017 Feb 13, 2018	SELL	$5.53 - $8.42 $397,054 - $604,556	-71,800 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$6.5 - $10.69 $466,700 - $767,542	71,800	71,800 $533,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.